On October 3, 2023, Zymergen, Subsidiary Of Ginkgo Bioworks And Certain Of Its Subsidiaries, Filed Voluntary Petitions For Relief Under Chapter 11 Of The United States Bankruptcy Code
On October 3, 2023, Zymergen Inc. (“Zymergen”), a wholly-owned subsidiary of Ginkgo Bioworks Holdings, Inc. (“Ginkgo”), and certain of its subsidiaries, filed voluntary petitions for relief under
